Shockwave Medical Future Growth
Future criteria checks 3/6
Shockwave Medical is forecast to grow earnings and revenue by 13.5% and 19.4% per annum respectively while EPS is expected to grow by 10.9% per annum.
Key information
13.5%
Earnings growth rate
10.9%
EPS growth rate
Medical Equipment earnings growth | 0% |
Revenue growth rate | 19.4% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 21 Nov 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 1,128 | 233 | N/A | N/A | 9 |
12/31/2024 | 919 | 174 | 221 | N/A | 11 |
12/31/2023 | 727 | 137 | 280 | N/A | 11 |
9/30/2023 | 671 | 244 | 143 | 177 | N/A |
6/30/2023 | 617 | 244 | 126 | 161 | N/A |
3/31/2023 | 557 | 241 | 121 | 150 | N/A |
12/31/2022 | 490 | 216 | 93 | 118 | N/A |
9/30/2022 | 430 | 88 | 69 | 86 | N/A |
6/30/2022 | 364 | 55 | 48 | 61 | N/A |
3/31/2022 | 299 | 29 | 23 | 34 | N/A |
12/31/2021 | 237 | -9 | 3 | 15 | N/A |
9/30/2021 | 176 | -38 | -29 | -18 | N/A |
6/30/2021 | 130 | -53 | -53 | -44 | N/A |
3/31/2021 | 84 | -71 | -75 | -64 | N/A |
12/31/2020 | 68 | -66 | -83 | -71 | N/A |
9/30/2020 | 59 | -65 | -83 | -71 | N/A |
6/30/2020 | 51 | -65 | -77 | -66 | N/A |
3/31/2020 | 51 | -57 | -66 | -58 | N/A |
12/31/2019 | 43 | -51 | -52 | -48 | N/A |
9/30/2019 | 34 | -48 | -48 | -45 | N/A |
6/30/2019 | 26 | -45 | -47 | -45 | N/A |
3/31/2019 | 18 | -44 | -47 | -45 | N/A |
12/31/2018 | 12 | -41 | -43 | -41 | N/A |
12/31/2017 | 2 | -31 | -31 | -30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SWAV *'s forecast earnings growth (13.5% per year) is above the savings rate (7.7%).
Earnings vs Market: SWAV *'s earnings (13.5% per year) are forecast to grow faster than the MX market (9.2% per year).
High Growth Earnings: SWAV *'s earnings are forecast to grow, but not significantly.
Revenue vs Market: SWAV *'s revenue (19.4% per year) is forecast to grow faster than the MX market (6.2% per year).
High Growth Revenue: SWAV *'s revenue (19.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SWAV *'s Return on Equity is forecast to be high in 3 years time